Patent ID: 11951093
Assignee: BODOR LABORATORIES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. An intra-oral composition, said composition comprising:
(a) at least one compound having the formula:, , wherein R is methyl or ethyl, said compound having the R stereoisomeric configuration at the 2 position and the R, S or RS stereoisomeric configuration at the 1′ and 3′ positions, or being a mixture thereof; and
(b) at least one anhydrous, non-toxic pharmaceutically acceptable carrier or excipient, wherein the carrier or excipient is suitable for intra-oral administration;, provided that said intra-oral composition is anhydrous; and that said intra-oral composition comprises an anti-excessive-salivation effective amount of from about 1 mg to about 10 mg per adult dose of the compound of formula (2), or from about 0.02 mg/kg to about 1.0 mg/kg per pediatric dose of the compound of formula (2).